Haima Therapeutics-preview

Haimatherapeutics

Haima Therapeutics

Private

Cleveland, OhioHealthcare & Life Scienceshttps://www.haimatherapeutics.com/

Last Round

Grant

Sep 19, 2025

Total Funding Raised

$6.63M

Momentum Score

50 /100

Company Overview

Haima Therapeutics is a biotechnology company that develops cell-inspired therapies to mitigate bleeding and other blood-related disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Defense Tech, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

synthetic plateletsSynthoPlatebleeding controlhemostatic agentblood surrogatesynthetic bloodartificial bloodnanoparticle therapeutictrauma medicinemilitary medicinehemorrhage controlsurgical bleedinglyophilized drugveterinary medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Haima Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Haima Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Sep 19, 2025
Grant	Jun 24, 2020
Grant	Feb 1, 2020
Grant	Oct 19, 2018
Grant	May 15, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Anirban Sen Gupta

Inventor, Co-founder And Chief Technology Officer

Founding Team

Christa L. Pawlowski

Co-Founder, Chief Operating Officer

Founding Team

Michael Bruckman

CEO, Chief Operating Officer, Director Of Technical Operations

Executive Team

Haima Therapeutics Investors

Notable investors and investment history

Investor	Rounds
NIH RADx	Grant
Ohio Third Frontier	Grant
U.S. Department of War	Grant
National Heart, Lung, and Blood Institute	Grant
Defense Advanced Research Projects Agency	Grant
National Science Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 2, 2026
Monthly visitors grew 4016% MoM, reaching 8.7K.
Sep 19, 2025
$4M grant from Defense Advanced Research Projects Agency

View all signals

Haima Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Haima Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Haima Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio

Employee Range16

Year Founded2016

Last FundingSep 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.